GeneDx Holdings Corp.
WGS
Updated: 24/09/2026, 02:58:21
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
No summaries found.
- Share price
- $85.20
- Market cap
- $2.54B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Katherine A. Stueland
- Employees
- 1,300
- IPO date
- 04/11/2020
- Beta
- 2.007
- Last dividend
- $0.00
- Day range
- $84.35 – $92.81
- 52-week range
- $32.21 – $170.87
- 1-day performance
- -6.17%
- 1-year performance
- 164.51%
- Current drawdown (1Y)
- -50.14%
- CIK
- 0001818331
- CUSIP
- 81663L200
- ISIN
- US81663L2007
- Created
- 07/12/2025, 15:05:10
- Last update
- 24/09/2026, 02:58:21
Track GeneDx Holdings Corp. with an AI analyst
See which prediction-market events move WGS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm
PRNewsWire • STOCK • 15/06/2026, 05:51:00
GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
PRNewsWire • STOCK • 14/06/2026, 18:54:00
ROSEN, TRUSTED TRIAL COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
Newsfile Corp • STOCK • 14/06/2026, 17:12:00
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
GlobeNewsWire • STOCK • 14/06/2026, 14:23:00
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWire • STOCK • 14/06/2026, 14:00:00
WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Newsfile Corp • STOCK • 14/06/2026, 10:10:00
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
Newsfile Corp • STOCK • 13/06/2026, 23:30:00
NASDAQ: WGS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)
GlobeNewsWire • STOCK • 13/06/2026, 13:30:00
WGS INVESTOR ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile Corp • STOCK • 13/06/2026, 01:05:00
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
GuruFocus • STOCK • 13/06/2026, 01:00:00
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
PRNewsWire • STOCK • 13/06/2026, 00:00:00
GeneDx Holdings Corp. (WGS) Investors: August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP
Business Wire • STOCK • 12/06/2026, 22:39:00